Skip to main content
Clinical Trials/NCT06303440
NCT06303440
Completed
Not Applicable

Effects of Virtual Reality Versus Motor Imagery on Balance, Gross Motor Function and Activities of Daily Living in Children With Cerebral Palsy.

Riphah International University1 site in 1 country63 target enrollmentFebruary 25, 2024
ConditionsCerebral Palsy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebral Palsy
Sponsor
Riphah International University
Enrollment
63
Locations
1
Primary Endpoint
Gross Motor Function Classification System
Status
Completed
Last Updated
last year

Overview

Brief Summary

Cerebral palsy is a neurodevelopmental disorder caused by brain injury that appears in infancy, children have mostly issues of gross motor functions, and activities of daily living. Virtual Reality is an innovative technique for the improvement of balance and motor function in most of the neurological conditions. Motor Imagery is an ability to engage in the mental representation of a task consciously without generating a voluntary movement. The aim of this study is to determine the comparative effects of Virtual Reality and Motor Imagery on balance, gross motor function and activities of daily living in children with cerebral palsy.

Detailed Description

This randomized controlled trial will be conducted at Rising Sun Institute. The sample size calculated for this trial will be 75. The participants will be randomly allocated using online randomization tool into three groups; Group A will receive routine physical therapy (PT) for 30 minutes with additional selected exercises for 15 minutes, Group B will receive VR training for 15 minutes with routine PT for 30 minutes, and Group C will receive MI for 15 minutes and routine PT for 30 minutes. Each participant will receive treatment for three days on alternative days per week for 12 weeks. Gross Motor Function Scale (GMFCS) will be used for balance, Bruininks-Oseretsky Test of motor function Proficiency-2 (BOT-2 ) for motor function, and WeeFIM scale for ADLs at baseline, 8th week, 12th week, and at 16th week after discontinuation of treatment.

Registry
clinicaltrials.gov
Start Date
February 25, 2024
End Date
August 31, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children of 7-12 years of both genders, Children with Mini Mental Scale score \>
  • Children with Gross motor function classification system (GMFCS) level I and II and able to follow and accept verbal instruction.

Exclusion Criteria

  • History of any Visual and Hearing Impairments, Virtual game phobia.
  • History of nerve, muscle, bone and joint diseases that seriously affect the movement function of the limbs and Children with history of severe cardiopulmonary disease, History of epilepsy, History of Fixed deformity of Lower limb. History of orthopaedic surgery and botulinum toxin injection.

Outcomes

Primary Outcomes

Gross Motor Function Classification System

Time Frame: 12 weeks

Gross Motor Function Classification System will be used to measure balance

Bruininks-Oseretsky Test of motor function Proficiency-2

Time Frame: 12 Weeks

It will be measured with Bruininks-Oseretsky Test of motor function Proficiency-2 for motor function.

Functional Independence Measure for Children

Time Frame: 12 Weeks

Functional Independence Measure for Children scale will be used to determine the Activities of Daily Living improvement.

Study Sites (1)

Loading locations...

Similar Trials